Bogdan Brodacki
Bogdan Brodacki has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Adam Stępień
Military Institute of Medicine – National Research Institute, Warsaw, Poland (A.D., J.S., A. Stępien)
3 shared publications - Jacek Staszewski
Clinic of Neurology, Military Institute of Medicine, Warsaw, Poland
3 shared publications - Renata Piusińska-Macoch
Military Institute of Medicine
3 shared publications - Ewa Skrobowska
Military Institute of Medicine
2 shared publications - Katarzyna Macek
Military Institute of Medicine
1 shared publication - Kazimierz Tomczykiewicz
Department of Neurology, Central Clinical Hospital of the Ministry of National Defense, Military Institute of Medicine, Warsaw, Poland
1 shared publication
Latest Publications
- Open Access
Risk of vascular events or death in different manifestations of cerebral small vessel disease: a 2-year follow-up study with a control group
Background and Purpose: Natural course of cerebral small vessel disease (CSVD) has not yet been thoroughly studied. The aim of the single center study was to establish risk of vascular events or death in different manifestations of CSVD. Methods: 150 consecutive, functionally independent patients with marked MRI features of CSVD and with recent lacunar stroke (n=52, LS), 20 with deep hemorrhagic stroke (HS), 28 with vascular parkinsonism (VaP), 50 with vascular dementia (VaD) and 55 controls (CG) with high atherothrombotic risk free of cerebrovascular events were prospectively recruited and followed for 24 months. Results: Mean age and sex distribution were similar in CSVD and CG but patients with CSVD were less likely to have CAD (19% vs 40%, p=0,02) and tended to have higher prevalence of diabetes (54% vs 37%, p=0,11). The risk of vascular events or death was increased in any patients with moderate to severe white matter lesions at baseline MRI (HR 2,0; 95%CI 0,85-7,2), in CSVD (4,56; 95%CI 1,3-14,9) vs CG, regardless of its clinical manifestation: LS or HS (HR 4,70; 95%CI 1,3-16,2) and VaD or VaP (HR 4,59; 95%CI 1,3-15,7). Conclusions: Patients with symptomatic CSVD regardless of the clinical (acute or chronic) manifestation had more than fourfold the risk of vascular events or death in 24 months of observation compared with controls with high atherothrombotic risk free of cerebrovascular events.
Open AccessRisk of vascular events or death in different manifestations of cerebral small vessel disease: a 2-year follow-up study with a control group
Background and Purpose: Natural course of cerebral small vessel disease (CSVD) has not yet been thoroughly studied. The aim of the single center study was to establish risk of vascular events or death in different manifestations of CSVD. Methods: 150 consecutive, functionally independent patients with marked MRI features of CSVD and with recent lacunar stroke (n=52, LS), 20 with deep hemorrhagic stroke (HS), 28 with vascular parkinsonism (VaP), 50 with vascular dementia (VaD) and 55 controls (CG) with high atherothrombotic risk free of cerebrovascular events were prospectively recruited and followed for 24 months. Results: Mean age and sex distribution were similar in CSVD and CG but patients with CSVD were less likely to have CAD (19% vs 40%, p=0,02) and tended to have higher prevalence of diabetes (54% vs 37%, p=0,11). The risk of vascular events or death was increased in any patients with moderate to severe white matter lesions at baseline MRI (HR 2,0; 95%CI 0,85-7,2), in CSVD (4,56; 95%CI 1,3-14,9) vs CG, regardless of its clinical manifestation: LS or HS (HR 4,70; 95%CI 1,3-16,2) and VaD or VaP (HR 4,59; 95%CI 1,3-15,7). Conclusions: Patients with symptomatic CSVD regardless of the clinical (acute or chronic) manifestation had more than fourfold the risk of vascular events or death in 24 months of observation compared with controls with high atherothrombotic risk free of cerebrovascular events.
- 1 December 2015
- Vol. 39 (234) , 398-404
[Pathogenesis and clinical manifestations of sporadic cerebral small vessel disease].
Sporadic small vessel disease (sSVD) is one of the most common vascular disease of the central nervous system (CNS). It is the main cause of lacunar stokes, hemorrhages to deep brain regions and chronic CNS diseases such as vascular parkinsonism and dementia. Beside a high and growing incidence of sSVD especially in the elderly population, the knowledge of ethiopathogenesis and optimal treatment of sSVD have not been established. The article summarizes different clinical manifestations (acute and chronic) as well as heterogenous radiologic changes found in CNS neuroimaging.
- 1 December 2015
- Vol. 39 (234) , 398-404
[Pathogenesis and clinical manifestations of sporadic cerebral small vessel disease].
Sporadic small vessel disease (sSVD) is one of the most common vascular disease of the central nervous system (CNS). It is the main cause of lacunar stokes, hemorrhages to deep brain regions and chronic CNS diseases such as vascular parkinsonism and dementia. Beside a high and growing incidence of sSVD especially in the elderly population, the knowledge of ethiopathogenesis and optimal treatment of sSVD have not been established. The article summarizes different clinical manifestations (acute and chronic) as well as heterogenous radiologic changes found in CNS neuroimaging.
- Open Access
- 30 September 2012
- Published by Elsevier in Perspectives in Medicine
- Vol. 1 (1-12) , 241-243
An increased frequency of right-to-left shunt in patients with chronic hyperventilation syndrome
- 30 September 2012
- Published by Elsevier in Perspectives in Medicine
- Vol. 1 (1-12) , 241-243
Open AccessAn increased frequency of right-to-left shunt in patients with chronic hyperventilation syndrome